Instil Bio TIL
NASDAQ TIL
$7.40 -0.11 (-1.46%)
As of: Sep 10, 2026 · 3:17 PM EDT

Instil Bio (TIL) Other Non-Current Assets (2020 - 2026)

Instil Bio (TIL) posted Other Non-Current Assets of $3.9 million for Q2 2026, down 1.93% on a QoQ basis from $4.0 million in Q1 2026, and down 65.1% year-over-year from $11.2 million in Q2 2025.

Analysis

Instil Bio (TIL) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Instil Bio has reported Other Non-Current Assets for 7 years, with the latest figure at $3.9 million in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets fell 65.1% year-over-year to $3.9 million in Q2 2026; TTM through Jun 2026 was $3.9 million, a 65.1% decrease from a year earlier, with the FY2025 full-year figure at $4.1 million, down 9.44% from the prior year.
  • Other Non-Current Assets was $3.9 million for Q2 2026 at Instil Bio, down from $4.0 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $11.2 million in Q2 2025, with the low at $581000.0 in Q2 2024.
  • Average Other Non-Current Assets over 5 years is $4.3 million, with a median of $3.9 million recorded in 2026.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets tumbled 81.25% in 2024, then soared 1827.88% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $3.4 million in 2022, then sank by 56.02% to $1.5 million in 2023, then soared by 199.13% to $4.5 million in 2024, then slipped by 9.44% to $4.1 million in 2025, then retreated by 3.86% to $3.9 million in 2026.
  • The last three Other Non-Current Assets figures came in at $3.9 million (Q2 2026), $4.0 million (Q1 2026), and $4.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 124.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 29.59 Mn
10 Instil Bio 50.19 Mn 50.19 Mn - 3.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.91 Mn
Mar 31, 2026 3.99 Mn
Dec 31, 2025 4.07 Mn
Sep 30, 2025 4.15 Mn
Jun 30, 2025 11.20 Mn
Mar 31, 2025 10.07 Mn
Dec 31, 2024 4.49 Mn
Sep 30, 2024 6.18 Mn
Jun 30, 2024 581,000.00
Mar 31, 2024 1.77 Mn
Dec 31, 2023 1.50 Mn
Sep 30, 2023 2.54 Mn
Jun 30, 2023 3.10 Mn
Mar 31, 2023 3.63 Mn
Dec 31, 2022 3.41 Mn
Sep 30, 2022 5.01 Mn
Jun 30, 2022 4.25 Mn
Mar 31, 2022 3.08 Mn
Dec 31, 2021 8.14 Mn
Sep 30, 2021 4.79 Mn